BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34240497)

  • 1. BMP9 and BMP10: Two close vascular quiescence partners that stand out.
    Desroches-Castan A; Tillet E; Bouvard C; Bailly S
    Dev Dyn; 2022 Jan; 251(1):178-197. PubMed ID: 34240497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the ALK1 ligands, BMP9 and BMP10.
    Li W; Salmon RM; Jiang H; Morrell NW
    Biochem Soc Trans; 2016 Aug; 44(4):1135-41. PubMed ID: 27528761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMP9, but not BMP10, acts as a quiescence factor on tumor growth, vessel normalization and metastasis in a mouse model of breast cancer.
    Ouarné M; Bouvard C; Boneva G; Mallet C; Ribeiro J; Desroches-Castan A; Soleilhac E; Tillet E; Peyruchaud O; Bailly S
    J Exp Clin Cancer Res; 2018 Aug; 37(1):209. PubMed ID: 30165893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMP10 functions independently from BMP9 for the development of a proper arteriovenous network.
    Choi H; Kim BG; Kim YH; Lee SJ; Lee YJ; Oh SP
    Angiogenesis; 2023 Feb; 26(1):167-186. PubMed ID: 36348215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Context-dependent signaling defines roles of BMP9 and BMP10 in embryonic and postnatal development.
    Chen H; Brady Ridgway J; Sai T; Lai J; Warming S; Chen H; Roose-Girma M; Zhang G; Shou W; Yan M
    Proc Natl Acad Sci U S A; 2013 Jul; 110(29):11887-92. PubMed ID: 23812757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of
    Hodgson J; Swietlik EM; Salmon RM; Hadinnapola C; Nikolic I; Wharton J; Guo J; Liley J; Haimel M; Bleda M; Southgate L; Machado RD; Martin JM; Treacy CM; Yates K; Daugherty LC; Shamardina O; Whitehorn D; Holden S; Bogaard HJ; Church C; Coghlan G; Condliffe R; Corris PA; Danesino C; Eyries M; Gall H; Ghio S; Ghofrani HA; Gibbs JSR; Girerd B; Houweling AC; Howard L; Humbert M; Kiely DG; Kovacs G; Lawrie A; MacKenzie Ross RV; Moledina S; Montani D; Olschewski A; Olschewski H; Ouwehand WH; Peacock AJ; Pepke-Zaba J; Prokopenko I; Rhodes CJ; Scelsi L; Seeger W; Soubrier F; Suntharalingam J; Toshner MR; Trembath RC; Vonk Noordegraaf A; Wort SJ; Wilkins MR; Yu PB; Li W; Gräf S; Upton PD; Morrell NW
    Am J Respir Crit Care Med; 2020 Mar; 201(5):575-585. PubMed ID: 31661308
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells.
    David L; Mallet C; Mazerbourg S; Feige JJ; Bailly S
    Blood; 2007 Mar; 109(5):1953-61. PubMed ID: 17068149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of ALK1-mediated signalling by BMP9/BMP10 and their prodomain-bound forms.
    Salmon RM; Guo J; Wood JH; Tong Z; Beech JS; Lawera A; Yu M; Grainger DJ; Reckless J; Morrell NW; Li W
    Nat Commun; 2020 Apr; 11(1):1621. PubMed ID: 32238803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygous GDF2 nonsense mutations result in a loss of circulating BMP9 and BMP10 and are associated with either PAH or an "HHT-like" syndrome in children.
    Hodgson J; Ruiz-Llorente L; McDonald J; Quarrell O; Ugonna K; Bentham J; Mason R; Martin J; Moore D; Bergstrom K; Bayrak-Toydemir P; Wooderchak-Donahue W; Morrell NW; Condliffe R; Bernabeu C; Upton PD
    Mol Genet Genomic Med; 2021 Dec; 9(12):e1685. PubMed ID: 33834622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone morphogenetic protein 9 (BMP9) and BMP10 enhance tumor necrosis factor-α-induced monocyte recruitment to the vascular endothelium mainly via activin receptor-like kinase 2.
    Mitrofan CG; Appleby SL; Nash GB; Mallat Z; Chilvers ER; Upton PD; Morrell NW
    J Biol Chem; 2017 Aug; 292(33):13714-13726. PubMed ID: 28646109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging roles of BMP9 and BMP10 in hereditary hemorrhagic telangiectasia.
    Tillet E; Bailly S
    Front Genet; 2014; 5():456. PubMed ID: 25620979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMP9 and BMP10 are critical for postnatal retinal vascular remodeling.
    Ricard N; Ciais D; Levet S; Subileau M; Mallet C; Zimmers TA; Lee SJ; Bidart M; Feige JJ; Bailly S
    Blood; 2012 Jun; 119(25):6162-71. PubMed ID: 22566602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BMP9 and BMP10 Act Directly on Vascular Smooth Muscle Cells for Generation and Maintenance of the Contractile State.
    Wang L; Rice M; Swist S; Kubin T; Wu F; Wang S; Kraut S; Weissmann N; Böttger T; Wheeler M; Schneider A; Braun T
    Circulation; 2021 Apr; 143(14):1394-1410. PubMed ID: 33334130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A heterodimer formed by bone morphogenetic protein 9 (BMP9) and BMP10 provides most BMP biological activity in plasma.
    Tillet E; Ouarné M; Desroches-Castan A; Mallet C; Subileau M; Didier R; Lioutsko A; Belthier G; Feige JJ; Bailly S
    J Biol Chem; 2018 Jul; 293(28):10963-10974. PubMed ID: 29789425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells.
    Upton PD; Davies RJ; Trembath RC; Morrell NW
    J Biol Chem; 2009 Jun; 284(23):15794-804. PubMed ID: 19366699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of heterozygous ALK1 mutations on the transcriptomic response to BMP9 and BMP10 in endothelial cells from hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension donors.
    Al Tabosh T; Liu H; Koça D; Al Tarrass M; Tu L; Giraud S; Delagrange L; Beaudoin M; Rivière S; Grobost V; Rondeau-Lutz M; Dupuis O; Ricard N; Tillet E; Machillot P; Salomon A; Picart C; Battail C; Dupuis-Girod S; Guignabert C; Desroches-Castan A; Bailly S
    Angiogenesis; 2024 May; 27(2):211-227. PubMed ID: 38294582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMP10-mediated ALK1 signaling is continuously required for vascular development and maintenance.
    Capasso TL; Li B; Volek HJ; Khalid W; Rochon ER; Anbalagan A; Herdman C; Yost HJ; Villanueva FS; Kim K; Roman BL
    Angiogenesis; 2020 May; 23(2):203-220. PubMed ID: 31828546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity and structure of a high affinity activin receptor-like kinase 1 (ALK1) signaling complex.
    Townson SA; Martinez-Hackert E; Greppi C; Lowden P; Sako D; Liu J; Ucran JA; Liharska K; Underwood KW; Seehra J; Kumar R; Grinberg AV
    J Biol Chem; 2012 Aug; 287(33):27313-25. PubMed ID: 22718755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the molecular regulation of endothelial BMP9 signalling complexes and implications for cardiovascular disease.
    Wood JH; Guo J; Morrell NW; Li W
    Biochem Soc Trans; 2019 Jun; 47(3):779-791. PubMed ID: 31127068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum/glucocorticoid-regulated kinase 1 as a novel transcriptional target of bone morphogenetic protein-ALK1 receptor signaling in vascular endothelial cells.
    Araki M; Hisamitsu T; Kinugasa-Katayama Y; Tanaka T; Harada Y; Nakao S; Hanada S; Ishii S; Fujita M; Kawamura T; Saito Y; Nishiyama K; Watanabe Y; Nakagawa O
    Angiogenesis; 2018 May; 21(2):415-423. PubMed ID: 29478089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.